Chemerin plasma levels are increased in COVID-19 patients and are an independent risk factor of mortality

Chemerin plasma levels are increased in COVID-19 patients and are an independent risk factor of mortality

BackgroundChemerin is an extracellular protein with chemotactic activities and its expression is increased in various diseases such as metabolic syndrome and inflammatory conditions. Its role in lung pathology has not yet been extensively studied but both known pro- and anti-inflammatory properties...

Full description

Bibliographic Details
Main Authors: Philomène Lavis, Sofia Morra, Carmen Orte Cano, Nurhan Albayrak, Véronique Corbière, Véronique Olislagers, Nicolas Dauby, Véronique Del Marmol, Arnaud Marchant, Christine Decaestecker, Françoise Mascart, Nathalie De Vos, Philippe Van de Borne, Isabelle Salmon, Myriam Remmelink, Marc Parmentier, Alessandra Kupper Cardozo, Benjamin Bondue
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Immunology
Subjects:
COVID-19
chemerin
ChemR23
CMKLR1
survival
ARDS
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.941663/full

Similar Items

Similar Items